1696 — Sisram Medical Income Statement
0.000.00%
Last trade - 00:00
- HK$1.57bn
- HK$1.52bn
- $359.29m
- 68
- 92
- 13
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 174 | 162 | 294 | 354 | 359 |
Cost of Revenue | |||||
Gross Profit | 95.9 | 90.3 | 167 | 202 | 220 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 148 | 144 | 250 | 308 | 319 |
Operating Profit | 25.6 | 17.7 | 44 | 46.7 | 40 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24.8 | 16.7 | 41.7 | 44.2 | 37.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.9 | 14.7 | 32.5 | 40.1 | 32.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.8 | 13.3 | 31.2 | 40.2 | 31.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.8 | 13.3 | 31.2 | 40.2 | 31.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.047 | 0.029 | 0.069 | 0.086 | 0.067 |
Dividends per Share |